Surrogacy Guide

China's assisted reproductive medical level has reached international advanced standards, with mature technical systems in conventional IVF, ICSI, PGT, and embryo vitrification. Clinical pregnancy rates are influenced by age, etiology, and center laboratory levels, with cumulative live birth rates of approximately 60%-70% for those under 35. This article analyzes technical capabilities, age stratification, center differences, and procedural standards.

Ovulation induction may trigger Ovarian Hyperstimulation Syndrome (OHSS), presenting symptoms such as bloating, abdominal pain, and nausea. This article provides a comprehensive explanation from the perspectives of medical mechanisms, risk factors, preventive measures, and monitoring procedures, helping patients correctly understand and scientifically manage OHSS risks.

Introduces official channels for verifying hospital qualifications in China, including the National Health Commission website, medical institution practice license inquiry, hospital grade inquiry, etc. Provides specific steps and precautions to help users identify legitimate hospitals and avoid being misled by false medical information.

China's vitrification technology has reached international advanced levels, with embryo survival rates exceeding 95% and egg freezing technology becoming increasingly mature. This article provides a comprehensive assessment of the true level of domestic vitrification technology from perspectives including technical principles, clinical application, success rates, and risk control.

Preimplantation Genetic Testing (PGT) in China has reached a mature stage of application, encompassing three types: PGT-A, PGT-M, and PGT-SR. This article systematically introduces the current status and key clinical applications of PGT technology in China from the perspectives of technical workflow, patient eligibility, testing accuracy, policy regulations, and clinical choices, helping patients understand the true capabilities and limitations of this technology.

Answering which hospitals in China offer Mandarin service: all licensed reproductive centers use Mandarin as their working language. For overseas Chinese and foreign patients, details on international departments, multilingual support, translation services, and communication plans to help eliminate language concerns in medical treatment.

Clearly answers whether unlicensed clinics in China can legally perform IVF and artificial insemination. Provides detailed interpretation of the

Which hospitals in China can perform PGT screening? This article lists major qualified PGT hospitals in China, including Peking University Third Hospital, Ruijin Hospital, the First Affiliated Hospital of Sun Yat-sen University, Tongji Hospital, etc., and explains PGT indications, procedures, costs, and selection considerations.

Answers the question of how IVF patients can maintain pregnancy after returning home. Covers luteal support protocols, HCG and progesterone monitoring, ultrasound scheduling, medication management, and handling abnormalities. No matter which fertility center you completed your transfer at, a standardized pregnancy maintenance process is needed after returning home.

Clinical value, technical principles, suitable populations, and limitations of the EmbryoScope time-lapse imaging incubator in Chinese reproductive centers. Based on real clinical observations, analyze the differences between dynamic embryo assessment and traditional culture to help patients and practitioners objectively understand this technology.

China's assisted reproductive technology ranks among the world's top tier, leading globally in annual cycles. An objective analysis of China's true international ranking and current status in assisted reproductive technology from multiple dimensions including clinical pregnancy rates, laboratory standards, and scientific research output.

China's hospital rankings have limited reference value in the field of assisted reproduction. The official assisted reproduction technology ranking published every two years by the National Health Commission (based on success rates, cycle numbers, and quality control) is the authoritative basis. Rankings like the Fudan version focus on scientific research reputation and do not directly reflect IVF clinical strength. When choosing a center, priority should be given to verifying whether the institution holds the NHC-approved qualification for human assisted reproductive technology, and to focus on core quality control indicators such as the live birth rate for fresh embryo transfers in women under 35, frozen embryo survival rate, and PGT-A detection accuracy.

How to identify illegal fertility clinics in China's assisted reproduction sector? This article provides actionable judgment methods from three dimensions: qualification verification, risk identification, and process validation. Key steps include verifying the medical institution license, confirming the qualifications of practicing physicians, and evaluating laboratory standards, helping patients avoid illegal medical practice traps and ensure treatment safety.

Evaluation dimensions for the service quality of Chinese assisted reproductive hospitals include clinical pregnancy rate, doctor-patient communication, process efficiency, and laboratory standards. Based on real patient feedback, this article analyzes the service characteristics of different reproductive centers and scientific selection criteria to help patients make appropriate decisions based on their own circumstances.

Jetanin Hospital provides Chinese translation, coordinators, and medical support for international patients. This article details Chinese service content, appointment methods, fee explanations, and precautions to help Chinese patients understand the treatment process and language arrangements in advance.

How to choose accommodation for IVF treatment away from home? This article systematically answers questions about IVF cycle accommodation arrangements from the perspectives of accommodation types, selection criteria, needs at different stages, time planning, cost references, and easily overlooked details, helping patients plan their medical stay reasonably.

CAP-accredited laboratories in China are mainly in assisted reproduction, including reproductive centers such as CITIC Xiangya and Peking University Third Hospital. To verify CAP accreditation, check the CAP official website or laboratory number. This article explains the accreditation standards and the list of domestic accredited laboratories.

Evaluating the level of reproductive medicine specialists in China requires multi-dimensional consideration of clinical experience, laboratory techniques, and individualized protocol design capabilities. Based on industry data and clinical practice, this guide objectively analyzes the professional level distribution of domestic reproductive medicine specialists, differences across hospital tiers, and patient selection strategies.

JCI-accredited reproductive hospitals in China include Peking University Third Hospital, Shanghai Renji Hospital, Obstetrics and Gynecology Hospital of Fudan University, and the First Affiliated Hospital of Sun Yat-sen University. JCI accreditation focuses on patient safety and continuous quality improvement. This article compiles a list of representative hospitals, analyzes the significance of accreditation, and provides selection considerations to help patients rationally evaluate medical quality.

China has JCI-accredited fertility hospitals. This article reviews the distribution, accreditation standards, practical value for patients, and verification methods of JCI-accredited reproductive centers in China, helping users objectively understand the significance and limitations of JCI accreditation in assisted reproduction.